The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis
Open accessThe DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Abstract
Epithelial–stromal interactions play a critical role in tumor initiation and progression; cancer-associated stroma, but not normal stroma, is known to be tumor-promoting. However, the molecular signal used by epithelial cancer cells to reprogram normal stroma to a tumorigenic stroma is not known. Here, we present evidence to suggest that the chemokine growth-regulated oncogene 1 (Gro-1) may be one such signaling molecule. We showed that the expression of Gro-1 is activated by RAS and is vital for cell survival and the malignant transformation of ovarian epithelial cells. Surprisingly, we found that Gro-1 is a potent inducer of senescence in stromal fibroblasts and that this effect depends on functional p53. Senescent fibroblasts induced by Gro-1 can promote tumor growth whereas abrogation of senescence through immortalization results in loss of such tumor promoting activity. We also demonstrated that stromal fibroblasts adjacent to epithelial cancer cells are senescent in human ovarian cancer specimens and in heterografts from RAS-transformed human ovarian epithelial cells and ovarian cancer cells. Moreover, Gro-1 was expressed at significantly higher amounts in ovarian cancer than in normal tissues and was higher in serum samples from women with ovarian cancer than in serum from women without ovarian cancer. These findings provide strong evidence that RAS-induced Gro-1 can reprogram the stromal microenvironment through the induction of senescence of fibroblasts and thus can promote tumorigenesis. Therefore, Gro-1 may be a therapeutic target as well as a diagnostic marker in ovarian cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Other SASP factors implicated in stimulating tumor cell growth are amphiregulin and the GROs (94–96), but there are a plethora of other candidates.”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [95]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Likewise, GROα, a potent mitogen that is a SASP component and is induced by oncogenic RAS, promotes the senescence of normal human ovarian fibroblasts (95).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [95]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Thus, oncogenes such as RAS, which are known to activate protumorigenic paracrine mechanisms during transformation [ 59 – 61 ], might also exert cell-nonautonomous protumorigenic effects through nontransformed cells during the process of inducing senescence ( Figure 7 D).”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [60]
The cited source says what the claim attributes to it.
In the citing paper
“the chemokine GRO1 (also known as CXCL1), which is secreted from transformed cells, can induce senescence in stromal fibroblasts 125”
From Inside and out: the activities of senescence in cancer (2014) · cites this paper as [125]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors
Campisi, J. (2005) · Cell · doi:10.1016/j.cell.2005.02.003 · Cited by 2,379
Stromal fibroblasts in cancer initiation and progression
Bhowmick, N. A., Neilson, E. G., & Moses, H. L. (2004) · Nature · doi:10.1038/nature03096 · Cited by 2,302
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
Friends or foes — bipolar effects of the tumour stroma in cancer
Mueller, M. M., & Fusenig, N. E. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1477 · Cited by 1,765
Krtolica, A., Parrinello, S., Lockett, S., Desprez, P.-Y., & Campisi, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211053698 · Cited by 1,730
Research works printed but not linked: 11
- AF Olumi, GD Grossfeld, SW Hayward, PR Carroll, TD Tlsty, GR Cunha Cancer Res 59, 5002–5011 (1999).
- E Balentien, BE Mufson, RL Shattuck, R Derynck, A Richmond Oncogene 6, 1115–1124 (1991).
- IM Shih, M Herlyn In Vivo 8, 113–123 (1994).
- Yang G, Rosen DG, Mercado-Uribe I, Colacino JA, Mills GB, Bast RC, Jr, Zhou C, Liu J (July 8, 2006) Carcinogenesis , 10.1093 ∕ carcin ∕ bgl115.
- Mok SC, Bell DA, Knapp RC, Fishbaugh PM, Welch WR, Muto MG, Berkowitz RS, Tsao SW (1993) Cancer Res 53:1489-1492.
- Ichikawa Y, Nishida M, Suzuki H, Yoshida S, Tsunoda H, Kubo T, Uchida K, Miwa M (1994) Cancer Res 54:33-35.
- Cuatrecasas M, Villanueva A, Matias-Guiu X, Prat J (1997) Cancer 79:1581-1586. · doi:10.1002/(sici)1097-0142(19970415)79:8<1581::aid-cncr21>3.0.co;2-t
- Cuatrecasas M, Erill N, Musulen E, Costa I, Matias-Guiu X, Prat J (1998) Cancer 82:1088-1095. · doi:10.1002/(sici)1097-0142(19980315)82:6<1088::aid-cncr12>3.0.co;2-2
- Bosman FT, de Bruine A, Flohil C, van der Wurff A, ten Kate J, Dinjens WW (1993) Int J Dev Biol 37:203-211.
- Krtolica A, Campisi J (2003) Adv Gerontol 11:109-116.
- Kacinski BM (1995) EXS 74:181-190.
Cited by
Items 201–300 of 348
Unraveling Adipocytes and Cancer Links: Is There a Role for Senescence?
Wu, Q., Li, B., Sun, S., & Sun, S. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00282 · Cited by 24
Liang, Y., Liang, N., Ma, Y., Tang, S., Ye, S., & Xiao, F. (2021) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2021.112343 · Cited by 25
Evidence of cellular senescence during the development of estrogen-induced pituitary tumors
Sabatino, M. E., Petiti, J. P., Sosa, L. D. V., Pérez, P. A., Gutiérrez, S., Leimgruber, C., Latini, A., Torres, A. I., & Paul, A. L. D. (2015) · Endocrine Related Cancer · doi:10.1530/erc-14-0333 · Cited by 28
Wang, Y., Xu, Q., Sack, L. M., Kang, C., & Elledge, S. J. (2016) · Genes & Development · doi:10.1101/gad.271445.115 · Cited by 24
“Several secreted factors have also been shown to be tumorigenic [94] [84].”
BackgroundStrategies for Delivery of siRNAs to Ovarian Cancer Cells
Farra, R., Maruna, M., Perrone, F. M., Grassi, M., Benedetti, F. M., Maddaloni, M., Boustani, M. E., Parisi, S., Rizzolio, F., Forte, G., et al. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11100547 · Cited by 24
Wang, L., Zhang, C., Xu, J., Wu, H., Peng, J., Cai, S., & He, Y. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5843 · Cited by 23
“CXCL1 is upregulated in melanoma, ovarian, colorectal and bladder cancer, and other tumors (5-8).”
Senescence as a modulator of oral squamous cell carcinoma development
Parkinson, E. K. (2010) · Oral Oncology · doi:10.1016/j.oraloncology.2009.09.009 · Cited by 26
Lugo, R., Gabasa, M., Andriani, F., Puig, M., Facchinetti, F., Ramírez, J., Gómez-Caro, A. A., Pastorino, U., Fuster, G., Almendros, I., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10327 · Cited by 25
Torti, D., Sassi, F. P., Galimi, F., Gastaldi, S., Perera, T. P. S., Comoglio, P. M., Trusolino, L., & Bertotti, A. (2011) · International Journal of Cancer · doi:10.1002/ijc.26137 · Cited by 22
“Both cytokines are transcriptionally upregulated by Ras-dependent signals, which are the major transducers of Metdriven growth in Met-addicted cancer cells.(14,24,25) They are involved in the progression of different types of tumors by stimulating angiogenesis and inflammatory reactions within the tumor reactive micro…”
BackgroundImmune Diseases Associated with Aging: Molecular Mechanisms and Treatment Strategies
Kim, M. E., & Lee, J. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115584 · Cited by 26
“The SASP has been implicated in a DNA-damage signaling mechanism [64].”
BackgroundBadiola, I., Santaolalla, F., García-Gallastegui, P., del Rey, A. S., Unda, F. J., & Ibarretxe, G. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.03.004 · Cited by 24
Hong, S., Zhang, X., Chen, J., Zhou, J., Zheng, Y., & Xu, C. (2013) · Journal of Ovarian Research · doi:10.1186/1757-2215-6-80 · Cited by 22
“Recent studies have shown that tissues and sera from patients with ovarian cancer have high levels of gro-α expression, while normal ovarian epithelial cells and fibroblasts have lower gro-α expression [20].”
BackgroundInfluentialThe Role of Senescence-Associated Secretory Phenotype in Bone Loss
Zhu, R., Wan, H., Yang, H. S., Song, M., Chai, Y., & Yu, B. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.841612 · Cited by 23
Senescent fibroblasts secrete CTHRC1 to promote cancer stemness in hepatocellular carcinoma
Huang, H., Peng, W., Zhou, Q., Zhao, Y., Liu, L., Cui, H., Liang, J., Cao, M., Chen, W., Wang, R., et al. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02369-8 · Cited by 20
“…HCC [75], hypoxia triggering nuclear factor erythroid 2-related factor 2 activation in esophageal cancer [15], and tumor-derived soluble factors such as the chemokine C-X-C motif chemokine ligand 1 in ovarian carcinoma [76] and inflammatory mediator interleukin-1α in colorectal adenocarcinoma [18].”
Wang, H., Yang, T., & Wu, X. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.06.003 · Cited by 20
Panda, S., Padhiary, S. K., & Routray, S. (2016) · Oral Oncology · doi:10.1016/j.oraloncology.2016.06.008 · Cited by 20
Amphotericin B up‐regulates angiogenic genes in hepatocellular carcinoma cell lines
Lin, Z., Chuang, W., & Chuang, Y.-H. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2008.02066.x · Cited by 20
In Arrayed Ranks: Array Technology in the Study of Mesothelioma
Gray, S. G., Fennell, D. A., Mutti, L., & O'Byrne, K. J. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181951ce8 · Cited by 21
Trachootham, D., Chen, G., Zhang, W., Lu, W., Zhang, H., Liu, J., & Huang, P. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.01.011 · Cited by 21
“The p53-deficient fibroblasts (NOF/hTERT shRNA p53) were established by stable transfection of immortalized non-tumorigenic fibroblasts (NOF/hTERT) with short-hairpin siRNA for p53 as described [19].”
MethodSelf-citationPakuła, M., Witucka, A., Uruski, P., Radziemski, A., Moszyński, R., Szpurek, D., Maksin, K., Woźniak, A., Sajdak, S., Tykarski, A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-44123-4 · Cited by 20
Liu, L., Huang, H., Cheng, B., Xie, H., Wang, P., Cui, H., Liang, J., Cao, M., Yang, Y., Chen, W., et al. (2024) · iScience · doi:10.1016/j.isci.2024.111612 · Cited by 22
Early inflammatory response in epithelial ovarian tumor cyst fluids
Kristjánsdóttir, B., Partheen, K., Fung, E. T., Yip, C., Levan, K., & Sundfeldt, K. (2014) · Cancer Medicine · doi:10.1002/cam4.282 · Cited by 19
“GROa is a potent inducer of senescence in stromal fibroblasts [38].”
BackgroundOyama, K., Iwagami, Y., Kobayashi, S., Sasaki, K., Yamada, D., Tomimaru, Y., Noda, T., Asaoka, T., Takahashi, H., Tanemura, M., et al. (2023) · International Journal of Cancer · doi:10.1002/ijc.34725 · Cited by 18
“30 Additionally, treated iSnCa cells acquire phenotypic and functional stemness-like features after escaping senescence.”
BackgroundThe induction of the fibroblast extracellular senescence metabolome is a dynamic process
James, E. N., Bennett, M. H., & Parkinson, E. K. (2018) · Scientific Reports · doi:10.1038/s41598-018-29809-5 · Cited by 18
Selection of p53-Deficient Stromal Cells in the Tumor Microenvironment
Farmaki, E., Chatzistamou, I., Bourlis, P., Santoukou, E., Trimis, G. G., Papavassiliou, A. G., & Kiaris, H. (2012) · Genes & Cancer · doi:10.1177/1947601912474002 · Cited by 17
Cellular Senescence in Liver Cancer: How Dying Cells Become “Zombie” Enemies
Gazzillo, A., Volponi, C., Soldani, C., Polidoro, M. A., Franceschini, B., Lleò, A., Bonavita, E., & Donadon, M. (2023) · Biomedicines · doi:10.3390/biomedicines12010026 · Cited by 15
Interaction of Immune and Cancer Cells
Klink, M. (2013) · Springer eBooks · doi:10.1007/978-3-7091-1300-4 · Cited by 18
Inflammation-induced Gro1 triggers senescence in neuronal progenitors: effects of estradiol
Zonis, S., Breunig, J. J., Mamelak, A. N., Wawrowsky, K., Bresee, C. J., Ginzburg, N., & Chesnokova, V. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1298-y · Cited by 15
“In multiple cell types, Gro1 appears to be a part of SAS [54, 63, 66].”
BackgroundCrosstalk between Thyroid Carcinoma and Tumor-Correlated Immune Cells in the Tumor Microenvironment
Song, M., Liu, Q., Sun, W., & Zhang, H. (2023) · Cancers · doi:10.3390/cancers15102863 · Cited by 14
Convergent evolution of senescent fibroblasts in fibrosis and cancer with aging
Lee, J. Y., & Peng, T. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.10.002 · Cited by 14
Ma, Y., Li, S., Ye, S., Luo, S., Wei, L. J., Su, Y., Zeng, Y., Shi, Y., Bian, H., & Xiao, F. (2024) · Environmental Pollution · doi:10.1016/j.envpol.2024.123535 · Cited by 14
Shi, H., Xiao, M., Li, Y., Liu, X., Na, J., Liang, C., Hua, J., Meng, Q., Wei, M., Wang, W., et al. (2025) · Theranostics · doi:10.7150/thno.112633 · Cited by 15
“During tumor initiation, senescent fibroblasts promoted ovarian tumorigenesis, as evidenced by reduced tumor growth following the abrogation of the senescence program [220].”
Pundlik, S. S., Barik, A., Venkateshvaran, A., Sahoo, S. S., Jaysingh, M. A., Math, R. G. H., Lal, H., Hashmi, M. A., & Ramanathan, A. (2024) · eLife · doi:10.7554/elife.95229 · Cited by 14
“…including proteins like growth factors, matrix metalloproteases, cytokines, and chemokines, and small molecules like fatty acid derivatives ( Campisi, 2005 ; Coppé et al., 2010 ; Dilley et al., 2003 ; Krtolica et al., 2001 ; Parrinello et al., 2005 ; Shelton et al., 1999 ; Yang et al., 2006 ).”
BackgroundSugimoto, Y., Okamoto, K., Saito, H., Yamaguchi, T., Kinoshita, J., Nakamura, K., Takino, T., Endo, Y., Ninomiya, I., Ohta, T., et al. (2024) · Oncology Reports · doi:10.3892/or.2024.8788 · Cited by 13
Lung cancer in chronic obstructive pulmonary disease patients. Does cellular senescence matter?
Kuźnar-Kamińska, B., Mikuła‐Pietrasik, J., Książek, K., Tykarski, A., & Batura‐Gabryel, H. (2018) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.4297 · Cited by 13
The Role of Chemokines in Migration of Metastatic-like Lymphangioleiomyomatosis Cells
Pacheco–Rodriguez, G., & Moss, J. (2010) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v30.i4.40 · Cited by 13
Zhang, M.-X., Hong, S., Cai, Q., Zhang, M., Chen, J., Zhang, X., & Xu, C. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1451934 · Cited by 12
“A previous study has reported that gro-a overexpression promotes the senescence of fibroblasts and ovarian tumorigenesis (Yang et al., 2006).”
BackgroundWan, X., Hong, Z., Mao, Y., & Di, W. J. (2020) · Translational Cancer Research · doi:10.21037/tcr.2019.11.47 · Cited by 12
“CXCL1 and CXCL2 are chemokines responsible for the regulation of mitogenic, pro-angiogenic processes, and their oncological roles are indicated in various cancers (17,18).”
BackgroundChemokine expression in patients with ovarian cancer or benign ovarian tumors
Nowak, M., Janas, Ł., Soja, M., Głowacka, E., Szyłło, K., Misiek, M., & Klink, M. (2021) · Archives of Medical Science · doi:10.5114/aoms/110672 · Cited by 12
“Moreover, CXCL1 was reported to stimulate fibroblast senescence to reprogram the stromal microenvironment, which in turn promoted the malignant transformation of epithelial cells [32].”
BackgroundZhuang, Z., Zhong, X., Chen, Q., Chen, H., & Liu, Z. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.857730 · Cited by 13
Mechanisms of Senescence in Cancer: Positive and Negative Aspects of Cancer Cells Senescence
Zaczek, A., Kalenik, S., & Rodacka, A. (2023) · Cellular Physiology and Biochemistry · doi:10.33594/000000671 · Cited by 12
Interleukin 32 promotes hematopoietic progenitor expansion and attenuates bone marrow cytotoxicity
Moldenhauer, A., Futschik, M. E., Lu, H., Helmig, M., Götze, P., Bal, G., Zenke, M., Han, W., & Salama, A. (2011) · European Journal of Immunology · doi:10.1002/eji.201040986 · Cited by 12
Senescence- and Immunity-Related Changes in the Central Nervous System: A Comprehensive Review
Feng, H., Li, J., Wang, H., Wei, Z., & Feng, S. (2024) · Aging and Disease · doi:10.14336/ad.2024.0755 · Cited by 11
Non‐pituitary growth hormone enables colon cell senescence evasion
Chesnokova, V., Zonis, S., Apaydın, T., Barrett, R. J., & Melmed, S. K. (2024) · Aging Cell · doi:10.1111/acel.14193 · Cited by 10
“We show here that induction of SASP-associated GH requires CXCL1, known to induce fibroblast senescence (Kim et al., 2018 ; Yang et al., 2006 ).”
Brücher, B. L. D. M., & Jamall, I. S. (2019) · 4open · doi:10.1051/fopen/2018996 · Cited by 10
The Dual Role of Senescence in Tumorigenesis
Chuaire, L., Sánchez, M. C., & Ramírez-Clavijo, S. R. (2010) · International Journal of Morphology · doi:10.4067/s0717-95022010000100006 · Cited by 13
Microbiome and morbid obesity increase pathogenic stimulus diversity
Brücher, B. L. D. M., & Jamall, I. S. (2019) · 4open · doi:10.1051/fopen/2018007 · Cited by 10
“CXCL1 binds neutrophils at sites of in fl ammation, is activated by RAS [134], and is reported to be a mitogen [135].”
BackgroundSenescent cell-derived vaccines: a new concept towards an immune response against cancer and aging?
Pessoa, J., Pereira, S. N., & de Jesus, B. B. (2024) · Aging · doi:10.18632/aging.205975 · Cited by 10
A fail-safe system to prevent oncogenesis by senescence is targeted by SV40 small T antigen
Oshikawa, K., Matsumoto, M., Kodama, M., Shimizu, H., & Nakayama, K. I. (2019) · Oncogene · doi:10.1038/s41388-019-1139-1 · Cited by 9
Li, T., Li, Y., Rehmani, H., Guo, J., Padia, R. N., Calbay, O., Ding, Z., Jiang, Y., Jin, L., & Huang, S. (2022) · Advances in Cancer Biology - Metastasis · doi:10.1016/j.adcanc.2022.100031 · Cited by 10
Yang, S. B., Han, F., Wu, J., Zhao, Z., & Zhan, W. (2016) · Oncology Letters · doi:10.3892/ol.2016.4790 · Cited by 8
Implications of chemokine receptors and inflammatory lipids in cancer
Maghazachi, A. A., & Rolin, J. (2013) · ImmunoTargets and Therapy · doi:10.2147/itt.s32049 · Cited by 8
“CXCL1/GRO-α, the ligand for CXCR1 and CXCR2, also serves to reprogram cancerassociated stromal fibroblasts to a senescent protumorigenic state in ovarian cancer.(106) Hence, CXCR2 and its ligands are regarded as gate keepers of tumor growth by increasing senescence.”
Uruski, P., Aniukiewicz, K., Mikuła‐Pietrasik, J., Sosińska, P., Tykarski, A., Książek, K., & Krasiński, Z. (2017) · BioMed Research International · doi:10.1155/2017/6167480 · Cited by 8
“Both groups of sera were compared with respect to a concentration of four arbitrarily selected cytokines (TGF-β1, GRO-1, TNFα, and IL-6), the activity of which has already been linked with the inhibition of cell growth [10] and the promotion of cellular senescence [11, 12] and oxidative stress [13, 14].”
BackgroundGROα expression and its prognostic implications in laryngeal squamous cell carcinoma
HAN, L., Liu, W., Chen, Y.-T., Wu, H., ZHANG, Y., & Jiang, B. (2015) · Neoplasma · doi:10.4149/neo_2015_020 · Cited by 8
Effectors and potential targets selectively upregulated in human KRAS-mutant lung adenocarcinomas
Li, J., Sordella, R., & Powers, S. (2016) · Scientific Reports · doi:10.1038/srep27891 · Cited by 8
Cancer Immunoediting: Elimination, Equilibrium, and Immune Escape in Solid Tumors
Wilczyński, J. R., & Nowak, M. (2013) · Springer eBooks · doi:10.1007/978-3-7091-1300-4_8 · Cited by 9
Tumour-Promoting Stromal Myofibroblasts in Human Carcinomas
Polanska, U. M., Mellody, K. T., & Orimo, A. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6615-5_16 · Cited by 9
“Several other independent studies have also confirmed the ability of CAFs extracted from a number of different human carcinomas to promote tumourigenesis (Olumi et al. 1999 ; Yang et al. 2006 ; Hwang et al. 2008 ; Hu et al. 2009 ) .”
BackgroundImpact of senescent fibroblasts secretome in ovarian cancer dissemination
Pèrié, L., Landras, A., Bignard, M., Theuret, M., Briand, M., Carreiras, F., & Picot, C. R. (2025) · Experimental Gerontology · doi:10.1016/j.exger.2025.112909 · Cited by 6
Targeting senescent cell clearance: An approach to delay aging and age-associated disorders
Qiu, Z., Jia, J., Zou, H., Ao, Y., Liu, B., & Wang, Z. (2021) · Translational Medicine of Aging · doi:10.1016/j.tma.2020.12.001 · Cited by 7
Ovarian Epithelial Carcinogenesis
Zhang, J., Silva, E. G., Sood, A. K., & Liu, J. (2019) · Springer eBooks · doi:10.1007/978-981-13-3019-3_4 · Cited by 7
Self-citationLee, S., & Lee, S. (2019) · Theriogenology · doi:10.1016/j.theriogenology.2019.12.014 · Cited by 6
Immunology and Immunotherapy of Ovarian Cancer
Wilczyński, J. R., & Nowak, M. (2015) · Springer eBooks · doi:10.1007/978-3-662-46410-6_22 · Cited by 6
Feng, Y. R., Zhi, X., Xiao, T., & Feng, L. (2026) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2026.112158 · Cited by 6
RAS Oncogenes and Tumor-Vascular Interface
Rak, J. W. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0711-0_7 · Cited by 17
Age-related functional decline of human B cells
Fujiki, T., Matsumoto, S., Kishihara, K., & Katakura, Y. (2022) · Cytotechnology · doi:10.1007/s10616-021-00513-z · Cited by 5
“Indeed, it has been suggested that B cells in old individuals may have a decreased function due to cellular senescence, and that the SASP may have implications in various diseases (Yang et al. 2006; Coppé et al. 2008; Rodier and Campisi 2011).”
BackgroundProspects of Modulating Protein–Protein Interactions
Zhong, S., Oashi, T., Yu, W., Shapiro, P., & MacKerell, A. D. (2012) · Wiley eBooks · doi:10.1002/9783527645947.ch15 · Cited by 6
Role of Chemokines and Chemokine Receptors in Cancer
Loyher, P.-L., Rodero, M. P., Combadière, C., & Boissonnas, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-30845-2_14 · Cited by 7
A regulatory biomimetic nanoparticle targeting senescent glioma cells for BNCT treatment
Dai, Q., Zhang, Z., Ben, Z., Sun, X., Yang, Y., Qin, Y., Yang, Q., Bao, X., Wu, L., Jiang, R., et al. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.174453 · Cited by 4
Self-citationChemokine-targeted nanoparticles: stimulation of the immune system in cancer immunotherapy
Singh, R. K., Srivastava, P., & Manna, P. P. (2023) · Exploration of Immunology · doi:10.37349/ei.2023.00093 · Cited by 4
Sheep stromal‐epithelial cell interactions and ovarian tumor progression
Wang‐Johanning, F., Huang, M. L., Liu, J., Rycaj, K., Plummer, J. B., Barnhart, K. F., Satterfield, W. C., & Johanning, G. L. (2007) · International Journal of Cancer · doi:10.1002/ijc.22960 · Cited by 4
“A recent study of normal ovarian stromal fibroblasts found that secretion of the RAS-induced chemokine growth-regulated oncogene 1 (Gro-1) by preneoplastic OSE cells induced senescence in normal fibroblasts, and that senescent fibroblasts induced by Gro1 can promote tumor growth.(29) Gro-1 links RAS signaling to the s…”
BackgroundSelf-citationMTA1 expression is linked to ovarian cancer
Murakami, M., Kaul, R., & Robertson, E. S. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.9.6885 · Cited by 4
[The effect of deep branches of cervical nerve on motorial function of trapezius muscle].
Wang, F., Wen, Y., & Li, L. (2003) · 华西口腔医学杂志 · Cited by 4
Neel, N. F. (2008) · Europe PMC (PubMed Central) · Cited by 4
Uruski, P., Mikuła‐Pietrasik, J., Tykarski, A., & Książek, K. (2025) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2025.112128 · Cited by 3
The Significance of CXCL1 in Cancer: An Overview of Molecular Mechanisms
Korbecki, J., Bosiacki, M., Dzięciołowska-Baran, E., Pawlik, P., Lubkowski, M., Walaszek, I., & Barczak, K. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27062693 · Cited by 3
Cellular senescence and chronic inflammation
Ohtani, N. (2014) · Japanese Journal of Clinical Immunology · doi:10.2177/jsci.37.390 · Cited by 3
Jin, L., Li, Z., Wang, D., Sun, M., Qi, W., Ma, Q., Zhang, L., Chu, C., Chan, E. Y. M., Lee, S. S. T., et al. (2017) · Cytokine · doi:10.1016/j.cyto.2017.12.019 · Cited by 3
Silva, A. O., Bitencourt, T. C., Vargas, J. E., Fraga, L. R., & Filippi‐Chiela, E. C. (2024) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2023-0311 · Cited by 4
“SASP contains high levels of growth factors such as Epidermal Growth Factor (EGF) and Vascular Endothelial Growth Factor (VEGF) (Strieter et al., 2006), transforming factors such as Gro-1 (Yang et al., 2006), molecules that stimulate the EMT such as TGF-β (Coppé et al., 2008), enzymes that promote the invasion of adja…”
BackgroundBalancing senescence and apoptosis: therapeutic insights into aging and cancer
Jan, N., Sofi, S., Mir, A. A., Masoodi, G., & Mir, M. A. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05355-3 · Cited by 4
“Similarly, GROα, a strong mitogen component of the SASP triggered by oncogenic RAS, promotes the senescence of normal human ovarian fibroblasts [131].”
Lin, W., Li, Z., Tsang, S.-Y., Lung, L. K., Wang, D., Chan, W. Y., Zhu, Y., Lee, S. S. T., & Cheung, W. (2009) · International Journal of Cancer · doi:10.1002/ijc.24440 · Cited by 3
Molecular Pathogenesis of Epithelial Ovarian Cancer
Bast, R. C., & Mills, G. B. (2008) · Elsevier eBooks · doi:10.1016/b978-141603703-3.10034-2 · Cited by 3
Self-citationThe Stem Cell Niche as the Key to Early Cancer Development
(2013) · Journal of Cytology & Histology · doi:10.4172/2157-7099.1000188 · Cited by 2
“It is known that cancer cells reprogram adjacent stromal cells so that the latter will optimize the environment by regulating energy metabolism to fuel cell growth and division [41,42].”
BackgroundXu, D., Li, S., Zhang, M., & Sun, Y. (2014) · Critical Reviews in Environmental Science and Technology · doi:10.1080/10643389.2013.852409 · Cited by 3
Follicle stimulating hormone receptor mediated gene delivery to target ovarian carcinoma in vitro
Dong, C. (2012) · Asian Biomedicine · doi:10.5372/1905-7415.0602.045 · Cited by 2
“It is well documented that CXCL1 is the key player and over expressed in many cancers, including in ovarian carcinomas [17-23].”
Ghosh, R., Schoolfield, J. D., Yeh, I., Smith, M. L., Hursting, S. D., Chan, D. C. F., Lucia, M. S., & Kumar, A. P. (2009) · Translational Oncology · doi:10.1593/tlo.08214 · Cited by 2
“Cytokine-induced neutrophil chemoattractant 2α is a counterpart of the human growth-regulated oncogene product that has been shown to be vital for cell survival and malignant transformation and activated by RAS [41].”
BackgroundThe Role of CXCR2 in Pancreatic Cancer Development and Progression
Purohit, A. (2015) · DigitalCommons@UNMC · Cited by 3
Ovarian Cancer in Elderly Patients
Freyer, G. (2015) · Springer eBooks · doi:10.1007/978-3-319-23588-2 · Cited by 2
Role of Chemokines and Chemokine Receptors in Cancer
Rodero, M. P., Combadière, C., & Boissonnas, A. (2014) · Springer eBooks · doi:10.1007/978-3-662-44006-3_8 · Cited by 2
Biological function of C-X-C Motif Chemokine Ligand 1 gene (CXCL1) in ovarian malignant tumors
Li, Z., Huang, N., Zhang, W., & Li, L. (2023) · Human & Experimental Toxicology · doi:10.1177/09603271231203392 · Cited by 1
Cytokines and Chemokines in Inflammation and Cancer
Hagemann, T., & Lawrence, T. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9781139195737.021 · Cited by 2
Immunology and Immunotherapy of Ovarian Cancer
Wilczyński, J. R., Nowak, M., & Wilczyński, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-57949-4_20 · Cited by 1
To G0 or Not to G0: Cell Cycle Paradox in Senescence and Brain Aging
Ishikawa, S., & Ishikawa, F. (2022) · Springer eBooks · doi:10.1007/978-981-16-7977-3_5 · Cited by 1
Senescence and the Microenvironment
Rai, M. K., Yadav, P., Katailiha, A. S., Singh, A. K., & Yadav, S. K. (2025) · Springer eBooks · doi:10.1007/978-981-96-1041-9_3 · Cited by 2
Swanson, E. C. (2014) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/m2k30f · Cited by 1
“SASP components, such as IL-6, IL-8, and WNT16B have also been shown to reinforce cell cycle arrest during oncogene induced senescence in vivo (Binet et al., 2009; Kuilman et al., 2008; Yang et al., 2006).”
BackgroundTreatment-Induced Tumor Cell Senescence and Its Consequences
Broude, E. V. (2008) · CRC Press eBooks · doi:10.3109/9781420020502-15 · Cited by 1
Regulation of Senescence by microRNAs
Grammatikakis, I., & Gorospe, M. (2013) · Wiley eBooks · doi:10.1002/9781118300312.ch4
Cancer Initiating Cells in Head and Neck Squamous Cell Carcinoma
Paramio, J. M. (2011) · BiblioBoard Library Catalog (Open Research Library) · doi:10.5772/19315
“…et al., 2005), and that the induction of senescence in the stromal cells (Krtolica et al., 2001; Liu and Hornsby, 2007; Parrinello et al., 2005; Yang et al., 2006) or the specific inactivation of certain pathways such LKB1 (Katajisto et al., 2008) or PTEN (Trimboli et al., 2009) in these…”
BackgroundTowner, L. D. (2013) · ORCA Online Research @Cardiff (Cardiff University)
Huang, S. (2013) · Digital Commons-TMC (Texas Medical Center)
The SDF-1-Rich Tumour Microenvironment Provides a Niche for Carcinoma Cells
Shimoda, M., Mellody, K. T., & Orimo, A. (2011) · Springer eBooks · doi:10.1007/978-94-007-0659-0_13
“The tumour-promoting ability of CAFs, which are stromal myofibroblast-rich cell populations extracted from human carcinoma, has been previously investigated using tumour xenograft models (Hu et al. 2009; Hwang et al. 2008; Olumi et al. 1999; Orimo et al. 2005; Yang et al. 2006 ).”
Background
Metadata
- Authors
- Yang, G., Rosen, D. G., Zhang, Z., Bast, R. C., Mills, G. B., Colacino, J. A., Mercado-Uribe, I., & Liu, J.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Experimental Therapeutics, and
- Departments of *Pathology,
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2006-10-31
- Volume
- 103
- Issue
- 44
- Pages
- 16472-16477
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1637606
- OpenAlex
- W1992742879
- Cited by
- 341
- References
- 49
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 19 · 2023: 23 · 2022: 15 · 2021: 12 · 2020: 15 · 2019: 16 · 2018: 19 · 2017: 9 · 2016: 28 · 2015: 26 · 2014: 23 · 2013: 26 · 2012: 12
- FWCI
- 8.86
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- Ras signaling, cellular senescence, stromal fibroblasts, ovarian cancer, stromal-epithelial interactions, cancer-associated stroma, p53, tumor microenvironment, malignant transformation, tumor growth promotion, serum biomarkers, therapeutic target
- MeSH terms
- Cell Transformation, Neoplastic, Cells, Cultured, Female, Fibroblasts, Gene Expression Regulation, Humans, Ovarian Neoplasms, Signal Transduction, Biomarkers, Tumor Suppressor Protein p53, Cellular Senescence, Stromal Cells, Apoptosis, ras Proteins, Chemokines, CXC, Chemokine CXCL1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.